"Penny Stocks to Watch Under 5¢ Now" $HNRC, $CLNV, $ENZC,

New Post Public Reply Private Reply Replies (0) Message Board
louied91
121
"Penny Stocks to Watch Under 5¢ Now" $HNRC, $CLNV, $ENZC, $SPZI, $HALB

https://www.marketscreener.com/quote/stock/HO...-45656976/

The penny stocks market continues to generate significant interest among investors as the year approaches its end. Given this scenario, it might be prudent for investors to explore specific undiscovered stocks within this niche. Here's a brief overview of five penny stocks trading below 5 cents per share that could be worth monitoring at this juncture.

Houston Natural Resources Corporation (OTC: HNRC), an oil and natural gas company, has stood out as a compelling player in the industry of late. The company established the SPAC entity known as HNR Acquisition Corp., an independent player in the oil and natural gas sector specializing in the acquisition, development, and exploration of properties in the Permian Basin.

On December 20, 2023, HNR Acquisition Corp. (NYSE: HNRA) gained prominence in search results following the revelation of its appointment of Dante Caravaggio as the new Chief Executive Officer. The official announcement highlighted Caravaggio's impressive executive background, citing his successful track record and previous roles at various large-cap companies.

On December 11, 2023, the company made headlines as its portfolio company, HNR Acquisition Corp. (NYSE: HNRA), completed a business combination on November 15, 2023. Through this transaction, HNR Acquisition Corp. (NYSE: HNRA) acquired all the equity interests in Pogo Resources LLC and its subsidiary, LH Operating LLC, making it an independent oil and natural gas company.

The company is set to engage in the acquisition, development, production, and exploration of oil and gas properties, particularly in the Permian Basin. Additionally, Houston Natural Resources Corporation (OTC: HNRC) owns interests in the Grayburg-Jackson oil field in the Permian Basin.

On November 13, 2023, the company attracted attention by announcing its financial results for the period ending on September 30, 2023. In the nine-month period, the company demonstrated strong performance compared to the same period in 2022. Total revenues for the period reached $15,241,815, marking a 5% year-on-year increase from the $14,462,094 generated in the previous year. Total earnings amounted to $8,871,912, reflecting a 9% year-on-year growth. The earnings per share for the nine-month period were $0.06, indicating a 20% improvement.

Clean Vision Corporation (OTC: CLNV): This emerging force in the $14 Trillion in the green energy and clean technology industry experienced a robust upward trend in its stock over the past week, accumulating gains of 6.21%. On December 5, 2023, the company disclosed the successful trademark approval for its clean hydrogen product, AquaH®, by the United States Patent and Trademark Office. Highlighting the innovation, the company emphasized the technology's capacity to generate carbon-neutral hydrogen, with a focus on utilizing waste plastic as a feedstock.

Enzolytics Inc. (OTC: ENZC) On November 20, 2023, it was revealed that Enzolytics Inc. had submitted a revised OTC Annual Report covering the period concluding on December 31, 2022, along with the overdue disclosure for the period concluding on September 30, 2023. The motivation behind the amendment of Enzolytics Inc.'s annual disclosure was to incorporate the audited financial statements for the periods ending on December 31, 2022, and December 31, 2021.

Spooz Inc. (OTC: SPZI) On December 26, 2023, the spotlight turned to the company following reports that its wholly owned subsidiary, JP Energy Global PTE LTD, had finalized a commodity contract valued at $53.46 million for Grade A Chicken Paws. The news release highlighted that the buyer had officially affirmed the contract on December 15, 2023. Additionally, Spooz subsidiary JP Energy Global issued a performance bond to the buyer, amounting to 2% of the financial operating instrument's total value.

Halberd Corporation (OTC: HALB) On December 13, 2023, the company made headlines following the revelation of a significant accord with the Canada-based CrodenHealth.com. According to the terms of the agreement, CrodenHealth.com is set to manufacture, sell, market, and distribute Halberd Corporation's globally patented low-dose naltrexone combo products. Furthermore, the agreement grants CrodenHealth.com the right of first refusal for the rights to other products within the developmental pipeline of Halberd Corporation.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 9

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 17

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 15

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 7

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 7

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 9

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 12

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading

Top 5 Most Recently Viewed Articles

Upcoming Earnings Announcements and Market Insights

Updated Category News Views 249

Companies Reporting Earnings Before The Market Opens Various companies are preparing for their quarterly earnings reports, each with expectations that could impact their stock performance in the market. For example, Bank of Hawaii is anticipated to report quarterly earnings of $1.05 per share on revenue of approximately $174.39 million. Similarly, Business First...

Continue Reading
Bloom Nutrition Unveils Bloom Pop: A Healthier Soda Choice

Updated Category News Views 425

Bloom Nutrition Introduces Bloom Pop Bloom Nutrition, the brand known for revolutionizing the wellness industry, has launched an exciting new product called Bloom Pop. This innovative soda is now available exclusively at Walmart, marking a significant step in the brand's journey towards making healthier options fun and accessible. A Bold and Bubbly Innovation Bloom Pop...

Continue Reading
Renault Surpasses Stellantis in European Car Market Growth

Updated Category News Views 502

Renault's Growth in the European Car Market Recent statistics reveal that new car sales in Europe showed a modest increase of 0.9% in 2024, primarily driven by a significant rise in hybrid vehicle registrations. This surge marks the fourth consecutive month where hybrid sales have surpassed those of petrol vehicles, indicating a pivotal shift in consumer preferences....

Continue Reading
Market Reactions Following Intense Presidential Debate Showdown

Updated Category News Views 91

Markets React to the Presidential Debate U.S. stock futures slipped and the dollar softened as investors watched a heated presidential debate reshape the political conversation. It was the first direct face-off between Republican candidate Donald Trump and Democratic Vice President Kamala Harris. Early reads from traders and analysts suggested Harris may have had the...

Continue Reading
Eli Lilly's Kisunla Gains Approval for Alzheimer's Treatment in UK

Updated Category News Views 81

Eli Lilly's Kisunla Gains Approval for Alzheimer's Treatment in the UK Eli Lilly and Company has recently celebrated a significant milestone with the approval of their innovative treatment, Kisunla™ (donanemab-azbt), for mild cognitive impairment and mild dementia associated with Alzheimer's disease. This groundbreaking therapy is specifically designed for adult...

Continue Reading